The European clinical, molecular, and pathological (ECMP) criteria and the 2007/2008 revisions of the World Health Organization for the diagnosis, classification, and staging of prefibrotic myeloproliferative neoplasms carrying the $JAK2^{V617F}$ Universiteit Antwerpen
Objective: The prefibrotic stages of JAK2(V617F) essential thrombocythemia (ET) and JAK2(V617F) polycythemia vera (PV) can easily be diagnosed clinically without use of bone marrow biopsy histology. We assessed the 2008 WHO and European Clinical, Molecular, and Pathological (ECMP) criteria for the diagnosis of myeloproliferative neoplasms (MPNs). Materials and Methods: Studied patients included 6JAK2(V617F)-mutated ET and 4 PV patients during ...